World's Best Scientists 2026 revealed!
Anthony L. Zietman

Anthony L. Zietman

D-Index & Metrics

Medicine

D-Index
91
Citations
33545
World Ranking
11678
National Ranking
5985

Anthony L. Zietman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anthony L. Zietman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 590 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anthony L. Zietman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony L. Zietman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Anthony L. Zietman is affiliated with Harvard University in the United States and has a significant body of research in the field of medicine, focusing primarily on oncology and urology. Their work spans several subfields including pulmonary and respiratory medicine, surgery, radiology, nuclear medicine and imaging, radiation, and oncology.

The scientist's main research topics cover a range of areas in cancer diagnosis, treatment, and radiotherapy. These include prostate cancer diagnosis and treatment, prostate cancer treatment and research, bladder and urothelial cancer treatments, advanced radiotherapy techniques, urinary and genital oncology studies, advances in oncology and radiotherapy, and cancer immunotherapy and biomarkers.

They have published extensively with frequent appearances in the following venues:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • The Journal of Urology
  • British Journal of Urology
  • The Lancet Oncology

Frequent collaborators include:

  • Jason A. Efstathiou (27 publications)
  • Sophia C. Kamran (20 publications)
  • William U. Shipley (17 publications)
  • David T. Miyamoto (15 publications)
  • Douglas M. Dahl (12 publications)

Significant recent papers authored or co-authored by Anthony L. Zietman include:

  • "Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I," 2020, The Journal of Urology
  • "Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis," 2023, The Lancet Oncology
  • "Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II," 2020, The Journal of Urology
  • "Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer," 2020, JAMA Oncology
  • "Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality," 2024, JAMA

The diversity of publication venues and the volume of research underscore their focus on clinical and research advances related to radiation and cancer treatment, with particular expertise in prostate and bladder cancers. This reflects interdisciplinary efforts combining oncology, radiology, surgery, and immunotherapy to advance therapeutic strategies and patient outcomes.

Best Publications

  • Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate : A randomized controlled trial

    Anthony L. Zietman;Michelle L. DeSilvio;Jerry D. Slater;Carl J. Rossi

  • Early detection of prostate cancer: AUA Guideline

    H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni

  • Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09

    Anthony L. Zietman;Kyounghwa Bae;Jerry D. Slater;William U. Shipley

  • Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

    Sam S. Chang;Bernard H. Bochner;Roger Chou;Robert Dreicer

  • Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

    Matthew R. Smith;Francis J. McGovern;Anthony L. Zietman;Mary Anne Fallon

  • Changes in body composition during androgen deprivation therapy for prostate cancer.

    Matthew R. Smith;Joel S. Finkelstein;Francis J. McGovern;Anthony L. Zietman

  • Prostate Specific Antigen Best Practice Statement: 2009 Update

    Kirsten L. Greene;Peter C. Albertsen;Richard J. Babaian;H. Ballentine Carter

  • Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    William U. Shipley;Wendy Seiferheld;Himanshu R. Lukka;Pierre P. Major

  • Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

    Peter Grimm;Ignace Billiet;David Bostwick;Adam P Dicker

  • Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

    William U. Shipley;Lynn J. Verhey;John E. Munzenrider;Herman D. Suit

  • Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

    Michael J. Zelefsky;Deborah A. Kuban;Larry B. Levy;Louis Potters

  • Pelvic normal tissue contouring guidelines for radiation therapy: A radiation therapy oncology group consensus panel atlas

    H. Joseph Barthold;Elizabeth O'Meara;Walter R. Bosch

  • Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

    William U. Shipley;Howard D. Thames;Howard M. Sandler;Gerald E. Hanks

  • Outcomes of localized prostate cancer following conservative management.

    Grace L. Lu-Yao;Peter C. Albertsen;Dirk F. Moore;Weichung Shih

  • American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

    Brian J. Davis;Eric M. Horwitz;W. Robert Lee;Juanita M. Crook

  • Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.

    Floyd J. Fowler;Mary McNaughton Collins;Peter C. Albertsen;Anthony Zietman

  • Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

    Jason A. Efstathiou;Daphna Y. Spiegel;William U. Shipley;Niall M. Heney

  • Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

    Raymond H. Mak;Daniel Hunt;William U. Shipley;Jason A. Efstathiou

  • Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer

    W.U Shipley;D.S Kaufman;E Zehr;N.M Heney

  • Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate Cancer

    Jeff M. Michalski;Colleen Lawton;Issam El Naqa;Mark Ritter

Frequent Co-Authors

William U. Shipley
William U. Shipley Harvard University
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
Michael J. Zelefsky
Michael J. Zelefsky Memorial Sloan Kettering Cancer Center
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center
Patrick A. Kupelian
Patrick A. Kupelian University of California, Los Angeles
Eric M. Horwitz
Eric M. Horwitz Fox Chase Cancer Center
Alvaro Martinez
Alvaro Martinez Beaumont Health
Paul L. Nguyen
Paul L. Nguyen Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens doors to many related online degree options, each offering distinct pathways in healthcare. If you’re interested in leadership roles, consider the cheapest online healthcare administration degree to combine medical knowledge with management skills.

For those seeking advanced expertise, there are affordable mha online programs and even the cheapest dnp options. These programs help students move into senior roles, such as executive positions or advanced clinical practice, at a lower cost than traditional on-campus options.

Pharmacists are also crucial to healthcare teams. If pharmacy piques your interest, look into online pharmacy programs to pursue this rewarding profession with more flexibility.

By researching affordable online degrees, you can chart a healthcare career path that fits both your professional aspirations and your budget.

Best Scientists Citing Anthony L. Zietman

Trending Scientists

Recently Published Articles